TG Therapeutics Inc (TGTX)

[Ecomike]

Todays news does not look good for old share holders, but may be good for new share holders. hard to tell at this point. Looks like this guy is now running the show, and all directors and officers at MHAN are gone, as of Dec 29th (a little late on that disclosure...)

http://www.opuspointpartners.com/ONEPAGERS/NHLD%20PR%20012511.pdf

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8332674

Name changed, share count went postal, they raises 11 million dollars, at .04/share

Personally I feel pretty screwed at this point here and wondering if Weiss has a history (Keryx Pharma?)

Mr. Weiss earned his J.D. from Columbia Law School and his B.S. in Finance from The University at
Albany. He began his professional career as a lawyer at Cravath, Swaine & Moore. In 1999, Mr. Weiss
founded ACCESS Oncology which was later acquired by Keryx Biopharmaceuticals (NASDAQ: KERX) in
2004. Following the merger, Mr. Weiss remained as Chairman & CEO of Keryx and grew Keryx to close
to a $1BB market capitalization company at its peak. During his tenure at Keryx, Mr. Weiss acquired
Keryx’s current Phase 3 drugs, raised over $150MM in equity capital through public and private offerings
to institutional investors and executed $100MM+ strategic alliance with Japan Tobacco Inc. and Torii
Pharmaceutical Co., Ltd. Such funds and fiscal discipline enforced by Mr. Weiss, enabled Keryx to
sustain itself through the economic turmoil of 2008-2009 without the need to conduct dilutive
financings, as was the case for many emerging companies. Prior to founding ACCESS Oncology, Mr.
Weiss was an investment banker and fund manager in New York City, focused on biotech and life
sciences.